Financial statements Duos Pharm Spółka Z Ograniczoną Odpowiedzialnością
Balance sheet data of DUOS PHARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
|
Year
|
2018
|
2019
|
2020
|
2021
|
2023
|
|---|---|---|---|---|---|
| Total assets | 4 807 275,87 | 4 648 376,47 | 5 239 799,50 | 6 082 509,60 | 5 575 764,48 |
| A. Fixed assets | 595 585,52 | 782 012,47 | 1 028 393,91 | 949 665,32 | 558 273,93 |
| B. Current assets | 4 211 690,35 | 3 866 364,00 | 4 211 405,59 | 5 132 844,28 | 5 017 490,55 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 4 807 275,87 | 4 648 376,47 | 5 239 799,50 | 6 082 509,60 | 5 575 764,48 |
| A. Equity | 1 092 487,32 | 718 050,76 | 688 267,76 | 934 775,98 | 351 553,22 |
| B. Liabilities and provisions for liabilities | 3 714 788,55 | 3 930 325,71 | 4 551 531,74 | 5 147 733,62 | 5 224 211,26 |
| I. Long-term liabilities | 111 760,00 | 46 780,00 | 890 193,25 | 207 124,50 | 0,00 |
| II. Short-term liabilities | 3 603 028,55 | 3 883 545,71 | 3 661 338,49 | 4 940 609,12 | 5 224 211,26 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.